4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001522780-25-000007
Director sold 25,000 shares at $30.00 ($750,000)
- Director acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaye Edward M. MD · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,000 | $0.60 | $15,000 | 74,124 | D |
| 2025-10-08 | Sale : show line 2 in the form 10b5-1 | −25,000 | $30.00 | $750,000 | 49,124 | D |
| Open-market sales · 25,000 sh · avg $30.00 · $750,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-08 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −25,000 | 542,801 | D |
Loading xslF345X05/form4-10102025_081021.xml…